Disease Overview：Atrial fibrillation（AFib）
Atrial fibrillation (AFib) is the most common sustained cardiac arrhythmia, characterized by disorganized electrical activity in the atria leading to irregular and often rapid ventricular response. It significantly increases the risk of stroke—fivefold—and contributes to heart failure, cognitive decline, and reduced quality of life. Pathophysiologically, AFib arises from ectopic triggers, typically originating in the pulmonary veins, and is associated with structural remodeling, fibrosis, and autonomic dysregulation. Risk factors include hypertension, aging, valvular heart disease, obesity, sleep apnea, and prior myocardial infarction. Clinical management encompasses rhythm control (via pharmacotherapy, catheter ablation, or cardioversion), rate control, and anticoagulation to mitigate thromboembolic risk—guided by CHA₂DS₂-VASc and HAS-BLED scoring.
China offers distinct advantages for AFib treatment: its cardiovascular centers perform over 100,000 catheter ablations annually—among the highest global volumes—with pioneering expertise in complex substrate-based ablation and hybrid surgical-epicardial approaches. Leading hospitals deploy state-of-the-art 3D electroanatomic mapping systems (e.g., CARTO 3, EnSite Precision), contact-force sensing catheters, and AI-assisted lesion assessment tools. Published outcomes demonstrate >85% single-procedure freedom from recurrent AFib at one year in paroxysmal cases, with low complication rates (<2% major adverse events). Crucially, comprehensive care—including advanced imaging, genomic-guided anticoagulation, and multidisciplinary follow-up—is delivered at approximately 40–60% of Western costs, without compromising evidence-based standards.
As a dedicated medical tourism agency, we facilitate seamless access to China’s top-tier cardiovascular programs: verifying hospital accreditation, coordinating specialist consultations, securing priority scheduling, clarifying all-inclusive pricing upfront, and providing end-to-end support—from visa assistance and travel logistics to post-procedure rehabilitation coordination and multilingual clinical liaison.
Atrial fibrillation: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Atrial Fibrillation (Cardiology Department)
Non-Surgical / Conservative Management
*Target Criteria:* Asymptomatic or mild symptoms, low stroke risk (CHA₂DS₂-VASc ≤1), stable hemodynamics, no structural heart disease contraindicating rate control.
- •Rate Control Medications (e.g., bisoprolol, digoxin, diltiazem):
- ECG monitoring (per visit): $8 - Liver/kidney function + electrolytes (baseline + q3mo): $45 - Annual echocardiogram (TTE): $110
- •Rhythm Control Medications (e.g., amiodarone, dronedarone, propafenone):
- Baseline & q3mo thyroid function + LFTs + chest X-ray: $75 - Annual Holter monitor (24-hr): $95
- •Anticoagulation Therapy (DOACs preferred: apixaban, rivaroxaban, edoxaban):
- Annual renal function + CBC: $30 - No routine INR monitoring required (vs. warfarin: $15/visit × 12 = $180/year)
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Symptomatic AF refractory to ≥2 antiarrhythmics; paroxysmal/persistent AF; LA diameter <55 mm; no contraindications to ablation (e.g., active endocarditis, severe LA thrombus).
- •Catheter Ablation (PVI ± substrate modification):
- Pre-op workup (TTE, CT angiography, blood coagulation panel, HbA1c, hepatitis screen): $320 - Hospital stay (3–5 days): $1,100–$1,800 - Post-ablation 7-day event monitor: $130
- •Surgical Maze (concomitant during CABG/valve surgery):
- *Not performed standalone in China due to invasiveness and lack of superiority over catheter ablation.*
Special / Complex Condition Options
- •Long-Standing Persistent AF (>12 months) with LA enlargement (>55 mm) or prior failed ablation:
- Pre-op cardiac MRI + advanced fibrosis mapping: $480
- •AF with High Stroke Risk + Contraindication to Anticoagulants (e.g., recurrent GI bleeding):
- Pre-op TEE + CT + anesthesia assessment: $390
Quick Selection Guide
- •<65 years, paroxysmal AF, no comorbidities, budget >$5k: First-line catheter ablation — highest long-term freedom from AF and drug burden.
- •≥75 years, CHA₂DS₂-VASc ≥3, frailty or bleeding history: DOAC + rate control — avoids procedural risk; optimal safety/cost balance.
- •Persistent AF + diabetes/hypertension + LA size 48–54 mm: Rhythm control drugs + early ablation referral — delays progression; ablation success remains >70%.
- •Recurrent AF post-ablation + LA fibrosis on MRI: Hybrid ablation — only option with proven efficacy in this subgroup.
- •Contraindicated anticoagulation + high stroke risk: LAAC — definitive stroke prevention without lifelong anticoagulation.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Atrial fibrillation Medical Vacation Packages
Curated transparent all-inclusive packages combining Atrial fibrillation treatment with China top medical destinations:
